INSYS Therapeutics Responds to Unsealing of Previously Filed Qui Tam Complaints and Recaps Transformation Efforts; Co. Best Est. Of Minimum Liability Exposure Of $150M In Aggregate Which It Expects To Be Paid Out Over 5 Years
Benzinga Newsdesk